APP and Alzheimer disease: Our study used 5xFAD transgenic mouse model of AD, which expresses human amyloid precursor protein (APP) and presenilin-1 (PS1) transgenes with five AD-linked mutations, and rapidly develops AD-related neuropathology and cognitive dysfunctions (Oakley et al., 2006).